BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20606540)

  • 1. The grading of lymphovascular space invasion in epithelial ovarian carcinoma.
    Qian X; Xi X; Jin Y
    Int J Gynecol Cancer; 2010 Jul; 20(5):895-9. PubMed ID: 20606540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of poor survival in ovarian cancer patients with high expression of SNAI2 and lymphovascular space invasion.
    Li J; Li S; Chen R; Lu X
    Oncotarget; 2017 Feb; 8(6):9672-9685. PubMed ID: 28039463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphovascular space invasion as a prognostic factor of epithelial ovarian cancer: a multicenter study by the FRANCOGYN group.
    Lorenzini J; Cirier J; Body G; Touboul C; Dabi Y; Collinet P; Coutant C; Akladios C; Lavoué V; Bolze PA; Huchon C; Bricou A; Canlorbe G; Ballester M; Carcopino X; Mimoun C; Bendifallah S; Ouldamer L;
    Arch Gynecol Obstet; 2021 Dec; 304(6):1577-1585. PubMed ID: 34184114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
    Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma.
    Matsuo K; Sheridan TB; Mabuchi S; Yoshino K; Hasegawa K; Studeman KD; Im DD; Rosenshein NB; Roman LD; Sood AK
    Gynecol Oncol; 2014 Jun; 133(3):473-9. PubMed ID: 24674832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of lymphovascular space invasion in epithelial ovarian cancer.
    Matsuo K; Sheridan TB; Yoshino K; Miyake T; Hew KE; Im DD; Rosenshein NB; Mabuchi S; Enomoto T; Kimura T; Sood AK; Roman LD
    Cancer Med; 2012 Oct; 1(2):156-64. PubMed ID: 23342265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.
    Matsuo K; Yoshino K; Hasegawa K; Murakami R; Ikeda Y; Adachi S; Hiramatsu K; Yokoyama T; Nishimura M; Sheridan TB; Enomoto T; Fujiwara K; Matsumura N; Konishi I; Fotopoulou C; Roman LD; Sood AK
    Gynecol Oncol; 2015 Feb; 136(2):198-204. PubMed ID: 25497604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.
    Matsuo K; Wong KK; Fotopoulou C; Blake EA; Robertson SE; Pejovic T; Frimer M; Pardeshi V; Hu W; Choi JS; Sun CC; Richmond AM; Marcus JZ; Hilliard MAM; Mostofizadeh S; Mhawech-Fauceglia P; Abdulfatah E; Post MD; Saglam O; Shahzad MMK; Karabakhtsian RG; Ali-Fehmi R; Gabra H; Roman LD; Sood AK; Gershenson DM
    J Surg Oncol; 2018 Feb; 117(2):236-244. PubMed ID: 28787528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion as a criterion for adjuvant chemotherapy for FIGO stage I-IIa clear cell carcinoma, mucinous, low grade serous and low grade endometrioid ovarian cancer.
    Delvallée J; Cancel M; Body G; Bendifallah S; Touboul C; Dabi Y; Collinet P; Coutant C; Akladios C; Lavoué V; Bolze PA; Huchon C; Bricou A; Canlorbe G; Ballester M; Carcopino X; Mimoun C; Darai E; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2021 Dec; 50(10):102193. PubMed ID: 34224900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The grading of lymphovascular space invasion in endometrial carcinoma.
    Hachisuga T; Kaku T; Fukuda K; Eguchi F; Emoto M; Kamura T; Iwasaka T; Kawarabayashi T; Sugimori H; Mori M
    Cancer; 1999 Nov; 86(10):2090-7. PubMed ID: 10570436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer.
    Alexander-Sefre F; Singh N; Ayhan A; Thomas JM; Jacobs IJ
    Gynecol Oncol; 2004 Feb; 92(2):653-9. PubMed ID: 14766262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases?
    Neal SA; Graybill WS; Garrett-Mayer E; McDowell ML; McLean VE; Watson CH; Pierce JY; Kohler MF; Creasman WT
    Gynecol Oncol; 2016 Aug; 142(2):278-82. PubMed ID: 27261326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer.
    Jorge S; Hou JY; Tergas AI; Burke WM; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2016 Mar; 140(3):387-93. PubMed ID: 26768835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular space invasion as a prognostic determinant in uterine cancer.
    Cheewakriangkrai C; Panggid K; Siriaungkul S; Khunamornpong S; Suprasert P; Srisomboon J
    Asian Pac J Cancer Prev; 2007; 8(3):363-6. PubMed ID: 18159968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Satellite lymphovascular space invasion: An independent risk factor in early stage cervical cancer.
    Pol FJ; Zusterzeel PL; van Ham MA; Kuijpers DA; Bulten J; Massuger LF
    Gynecol Oncol; 2015 Sep; 138(3):579-84. PubMed ID: 26126782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium.
    Desrosiers L; Fadare O; Xiao ZF; Dresser K; Wang SA
    Ann Diagn Pathol; 2008 Apr; 12(2):112-7. PubMed ID: 18325471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular space invasion and estrogen receptor status in high-grade serous ovarian cancer - A multicenter study by the FRANCOGYN group.
    Lorenzini J; Deberti M; Body G; Carcopino X; Touboul C; Dabi Y; Collinet P; Coutant C; Akladios C; Lavoué V; Bolze PA; Huchon C; Bricou A; Canlorbe G; Mimoun C; Bendifallah S; Ouldamer L;
    J Gynecol Obstet Hum Reprod; 2022 Jan; 51(1):102242. PubMed ID: 34715402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
    Weinberg LE; Kunos CA; Zanotti KM
    Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of P53, COX2 and CD44V6 in early-stage squamous carcinoma of cervix with lymph vascular space invasion positive and negative and its relationship with prognosis].
    Zhang R; Song Y; Gao WJ; Zhang X; Zuo J; Lei CZ; Wang Y
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3341-5. PubMed ID: 20193563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.
    dos Reis R; Burzawa JK; Tsunoda AT; Hosaka M; Frumovitz M; Westin SN; Munsell MF; Ramirez PT
    Int J Gynecol Cancer; 2015 Sep; 25(7):1292-9. PubMed ID: 26067863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.